Loading stock data…
QDEL
$12.64+0.34 (+2.76%)
Market ClosedLast close May 1
QuidelOrtho Corporation provides diagnostic testing solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
QuidelOrtho Corporation in the Healthcare sector is trading at $12.64. The stock is currently near its 52-week low of $10.86, remaining 49.0% below its 200-day moving average. Technical signals show neutral RSI of 34 and bullish MACD crossover, explaining why QDEL maintains its current current market pressure. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 34) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$12.64
Potential Upside
5%
Whystock Fair Value$13.27
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Buy
Mean target$27.00+113.6%
Range$15.00 – $38.00
Fundamentals
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$810.17M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.92
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-24.29%
Volume
Today's trading volume
1.37M
Recent News
Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline
QuidelOrtho (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Out-of-Favor Stocks We Steer Clear Of
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Why Diagnostics Names CareDx And QuidelOrtho Just Diverged
Medical products outlets CareDx and QuidelOrtho diverged Thursday on incredibly different updates heading into their first-quarter reports.
This Diagnostics Stock Is Sinking 27%. Why the Moderate Flu Season Was Bad for Business.
QuidelOrtho shares are sinking on Thursday after the diagnostics testing company announced preliminary first-quarter revenue.
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the Stat